- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.09. | Neola Medical AB: Neola Medical Receives FDA Breakthrough Device Designation | 249 | GlobeNewswire (Europe) | Neola Medical AB (publ) today announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for Neola®, the Company's medical device for non-invasive, continuous... ► Artikel lesen | |
| 31.08. | Neola Medical AB: Neola Medical Granted U.S. Design Patent Strengthening Protection of Neola User Interface | 268 | GlobeNewswire (Europe) | Neola Medical AB (publ) today announces that the United States Patent and Trademark Office (USPTO) has granted the company a design patent covering the graphical user interface of Neola®. The patent... ► Artikel lesen | |
| NEOLA MEDICAL Aktie jetzt für 0€ handeln | |||||
| 20.08. | Neola Medical weitet Verlust in Q2 2026 aus - Aktie gibt nach | 5 | Investing.com Deutsch | ||
| 20.08. | Neola Medical AB Q2 Loss Widens | 2 | RTTNews | ||
| 20.08. | Neola Medical AB: Neola Medical Q2 Report 2026 - Clinical progress, secured financing and sharpened focus | 175 | GlobeNewswire (Europe) | During the quarter, Neola Medical reported positive safety results from its first clinical pilot study in preterm born babies in Sweden. The study confirmed a favorable safety profile of Neola® and... ► Artikel lesen | |
| 10.06. | Neola Medical AB: Neola Medical granted Patent in the U.S. for reducing optical noise in lung monitoring measurements | 182 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted a patent in the U.S. for a technical solution that reduces noise in measurements for continuous lung monitoring. The patent protects an innovation designed to... ► Artikel lesen | |
| 02.06. | Listing of subscription rights and paid subscription shares of Neola Medical AB | 324 | GlobeNewswire | With effect from June 03, 2026, the subscription rights in Neola Medical AB will be traded on First North Growth Market. Trading will continue up until and including June 12, 2026.
... ► Artikel lesen | |
| 19.05. | Neola Medical AB: Neola Medical Q1 Report 2026 - Positive safety results from clinical study in preterm born babies strengthen the path toward market | 220 | GlobeNewswire (Europe) | During the quarter, Neola Medical completed enrollment and reported positive safety results from its first clinical pilot study in preterm born babies in Sweden. The study confirmed a favorable safety... ► Artikel lesen | |
| 21.04. | Neola Medical AB: Neola Medical Reports Positive Safety Results from First Clinical Pilot Study and Advances Towards Next Phase of Clinical Development | 177 | GlobeNewswire (Europe) | Neola Medical today announces final results from its clinical pilot study, confirming a favorable safety profile of Neola® across the studied patient population, including very low birth weight preterm... ► Artikel lesen | |
| 16.03. | Neola Medical AB: Neola Medical Completes Enrollment in Swedish Clinical Pilot Study | 444 | GlobeNewswire (Europe) | Neola Medical announces completion of patient enrollment in its clinical pilot study on preterm born babies in Sweden. All ten babies have now been included in the study, marking an important milestone... ► Artikel lesen | |
| 12.02. | Neola Medical AB: Neola Medical Q4 Report 2025 - Advancing IP Protection as a Core Strategic Asset across Key Markets | 198 | GlobeNewswire (Europe) | During the quarter four new patents were granted, adding in total of seven new patent grants during 2025. This marks Neola Medical's strongest year to date in terms of IP protection across all key target... ► Artikel lesen | |
| 02.12.25 | Neola Medical AB: Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market | 231 | GlobeNewswire (Europe) | Neola Medical AB (publ) announces today that the company has been granted a U.S. patent protecting its disposable probes for the medical device Neola®. The advanced light and detector probes are used... ► Artikel lesen | |
| 13.11.25 | Neola Medical AB: Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements | 244 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted its first patent in China for a technical solution that reduces noise in measurements for continuous lung monitoring. The patent protects an innovation designed... ► Artikel lesen | |
| 04.11.25 | Neola Medical AB: Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola | 204 | GlobeNewswire (Europe) | Preliminary results from Neola Medical's ongoing clinical pilot study on preterm born babies indicate a robust safety profile of the medical device Neola®.
The preliminary findings indicate variations... ► Artikel lesen | |
| 04.11.25 | Neola Medical AB: Neola Medical Q3 Report 2025 - Progressing toward completion of Swedish clinical pilot study and strengthening leadership team | 169 | GlobeNewswire (Europe) | During the quarter Neola Medical strengthened the leadership team with appointment of a Clinical Director. In addition, the company's IP portfolio was reinforced in Europe with a newly granted patent... ► Artikel lesen | |
| 16.10.25 | Neola Medical AB: Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola | 238 | GlobeNewswire (Europe) | Neola Medical AB (publ) has been granted patents in both the U.S. and China for a technical method that improve the accuracy of continuous lung monitoring with the company's medical device, Neola®.... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,150 | +0,91 % | Fresenius baut Kapazität in Europa für 54 Mio Euro aus | DJ Fresenius baut Kapazität in Europa für 54 Mio Euro aus
DOW JONES--Fresenius hat seine Kapazitäten für die Herstellung von Infusionslösungen in Polen und Italien erweitert. Wie der DAX-Konzern... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,790 | +1,56 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,800 | +1,14 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,215 | +0,06 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,410 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 56,61 | +0,04 % | Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve? | ||
| FIREFLY NEUROSCIENCE | 2,020 | +0,50 % | Firefly Neuroscience und NeuroSigma kooperieren bei ADHS-Behandlung | ||
| LIFESTANCE HEALTH GROUP | 11,835 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 17,190 | -0,06 % | Procept BioRobotics verlängert Kreditlaufzeit mit CIBC um ein Jahr | ||
| CARL ZEISS MEDITEC | 31,060 | -1,52 % | 12 Prozent bessere Leistung, 14 Prozent weniger Belastung: Warum ZEISS das Brillenglas neu denkt - und wo Rise Nano Optics ins Spiel kommt | ||
| PRIVIA HEALTH GROUP | 19,725 | +0,08 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| BILLIONTOONE | 123,25 | +0,14 % | Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently | ||
| GENEDX | 88,40 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| INNOVAGE | 9,000 | 0,00 % | InnovAge Holding Corp. - 8-K, Current Report | ||
| HEARTFLOW | 49,210 | 0,00 % | Canaccord raises HeartFlow stock price target on plaque analysis survey |
Das Unternehmen NEOLA MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEOLA MEDICAL AB finden Sie auf Wallstreet Online.